Irina Chelysheva

Irina Chelysheva is a Senior Lecturer in Human Genomics at the School of Biological and Medical Sciences, Oxford Brookes University, where she established her research group in 2025. She previously held senior postdoctoral and teaching roles at the University of Oxford, including at the Oxford Vaccine Group and Centre for Human Genetics.

• Medical Degree: Russian National Research Medical University
• PhD: Biochemistry and Molecular Biology, University of Hamburg
• MSc: Economics (Health Economics), University of Hamburg

Her research integrates genomics, immunology, and microbiology to study host-pathogen interactions through computational and experimental approaches. Current projects focus on microbiome research using Oxford Nanopore sequencing, while past work includes vaccine trial analysis, GWAS, RNA-seq, and bacterial translation studies.

Key trends in her recent publications include SARS-CoV-2 vaccine immunogenicity, HLA allele associations with breakthrough infections, RNA-seq quality control, and microbiome profiling. Her work spans both clinical and computational domains.

• Scientific Awards: Fellow of the Higher Education Academy (FHEA)
• Professional Memberships: British Society for Immunology, BactiVac Network, Oxford Microbiome Network, HIC-Vac Network